Global MRSA Drugs Market 2016-2020

SKU ID : TNV- 10279642

Publishing Date : 27-Jul-2016

No. of pages : 79

PRICE
2500
4000

  • About Methicillin-Resistant Staphylococcus aureus (MRSA)

    MRSA is an infection of the skin that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and usually spreads from person to person by direct skin-to-skin contact. Physicians often find MRSA harder to treat than most other strains of Staphylococcus aureus because it is sometimes resistant to commonly-used antibiotics such as methicillin.

    Technavio’s analysts forecast the global MRSA drugs market to grow at a CAGR of 1.34% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global MRSA drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent MRSA infections.

    The market is divided into the following segments based on geography:
    • Americas
    • APAC
    • EMEA

    Technavio's report, Global MRSA Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Allergan
    • Merck & Co.
    • Pfizer
    • Theravance Biopharma

    Other prominent vendors
    • Absynth Biologics
    • AmpliPhi Biosciences Corporation
    • AstraZeneca
    • Basilea Pharmaceutica
    • Baxter International
    • Cellceutix
    • Cempra Inc.
    • CrystalGenomics
    • Debiopharm Group
    • Galapagos NV
    • GSK
    • KYORIN Pharmaceutical
    • Lytix Biopharma
    • Melinta Therapeutics
    • Nabriva Therapeutics
    • NovaDigm Therapeutics
    • Paratek Pharmaceuticals
    • R-Pharm
    • Savara Pharmaceuticals
    • Sealife Pharma
    • Sequella Inc.
    • The Medicines Company
    • XBiotech

    Market driver
    • Special regulatory designations
    • For a full, detailed list, view our report

    Market challenge
    • Development of drug-resistant strains
    • For a full, detailed list, view our report

    Market trend
    • Strategic alliances and M&A
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.










    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports